Literature DB >> 4004175

Facioscapulohumeral dystrophy presenting in infancy with facial diplegia and sensorineural deafness.

B R Korf, M J Bresnan, F Shapiro, A Sotrel, I F Abroms.   

Abstract

Six patients are described in whom facial diplegia occurred in the first year of life, with subsequent development of facioscapulohumeral dystrophy. All had severe progressive disability prior to adolescence. Facial involvement did not include extraocular muscles. All six patients had a sensorineural hearing loss. Evidence of a mildly affected parent was found in three families. Progressive and severe facioscapulohumeral dystrophy accompanied by facial diplegia and sensorineural hearing loss may represent a separate genetic form of facioscapulohumeral dystrophy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4004175     DOI: 10.1002/ana.410170516

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  5 in total

Review 1.  Muscular dystrophies.

Authors:  L Specht
Journal:  Indian J Pediatr       Date:  1990 May-Jun       Impact factor: 1.967

2.  De novo facioscapulohumeral muscular dystrophy defined by DNA probe p13E-11 (D4F104S1).

Authors:  P E Jardine; M C Koch; P W Lunt; J Maynard; K D Bathke; P S Harper; M Upadhyaya
Journal:  Arch Dis Child       Date:  1994-09       Impact factor: 3.791

3.  Genetic counselling in facioscapulohumeral muscular dystrophy.

Authors:  P W Lunt; P S Harper
Journal:  J Med Genet       Date:  1991-10       Impact factor: 6.318

4.  Severe visual loss associated with retinal telangiectasis and facioscapulohumeral muscular dystrophy.

Authors:  D Pauleikhoff; N Bornfeld; A C Bird; A Wessing
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

5.  Effects of weakness of orofacial muscles on swallowing and communication in FSHD.

Authors:  Karlien Mul; Kiera N Berggren; Mattie Y Sills; Ayla McCalley; Baziel G M van Engelen; Nicholas E Johnson; Jeffrey M Statland
Journal:  Neurology       Date:  2019-01-25       Impact factor: 9.910

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.